Autor/es reacciones

Karen Noble

Director of Research, Policy and Innovation at Brain Tumour Research (UK)

Any increased understanding of the risk factors of brain tumours is beneficial to the brain tumour community; it may open doors to research on preventative measures, as well as increase our understanding of why these tumours arise in the first place. However, the public needs to be cautious when digesting the results from a study such as this before taking action. Although this study has linked certain progestogen treatments to an increased risk of meningioma, it has also demonstrated the safety of other progestogen treatments which were shown to not increase risk. If you are concerned, it is recommended that you speak to your GP before stopping any prescribed treatment.

EN